Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies

This study has been terminated.
(Terminated due to slow accrual)
Information provided by (Responsible Party):
Human Genome Sciences Inc. Identifier:
First received: November 3, 2009
Last updated: August 1, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)